Dosing considerations Administer for at least 2 days and then continue until clinical stabilization Usual duration of treatment is 2-8 days; up to 12.5 days has been administered in clinical trials Acute Coronary Syndromes Non-ST elevation myocardial infarction (NSTEMI): 1 mg/kg SC q12hr; coadmi...
Dosing of Enoxaparin ( Lovenox ) in Special Patient PopulationsPharmacist S Letter Prescriber S Letter
Dosing Regimen† IndicationLovenox 1.5 mg/kg daily subcutaneouslyLovenox 1 mg/kg q12h subcutaneouslyHeparin aPTT Adjusted Intravenous Therapy * Bleeding complications were considered major: (1) if the hemorrhage caused a significant clinical event, or (2) if accompanied by a hemoglobin decrease ≥2...
Modified dosing for patients with severe renal impairment (CrCl <30 mL/min) across all indications Elderly patients Low-weight patients Patient self-injection videoIf your patients are going home with Lovenox self-injectables, this video provides helpful instructions. ...
For treatment of acute ST-segment elevation myocardial infarction in geriatric patients ≥75 years of age, do not use an initial intravenous bolus. Initiate dosing with 0.75 mg/kg subcutaneously every 12 hours (maximum 75 mg for the first two doses only, followed by 0.75 mg/kg dosing for th...